Go to content

8. Emission sector contributions to health effects and external costs in 2030

Based on the urban background concentrations modelled with UBM for the Nordic capital cities, the EVA-system has been used to model the share of health effects and related external costs from individual emission sectors in each selected Nordic capital city in 2030 sub-divided by transboundary, country, and city boundaries.

8.1 Assumptions

Population data in 2019 and 2030

The population data applied in the current version of the EVA system are based on information from Eurostat. 
The most recent gridded population dataset from Eurostat is valid for 2018 on a 1 km x 1 km grid (https://ec.europa.eu/eurostat/web/gisco/geodata/reference-data/population-distribution-demography/geostat). In this project, this distribution has been scaled so the annual totals sum up to the available reported and projected national totals in the specific years of 2019 and 2030. A baseline projection of the development in national totals and the age distribution for 2030 has also been obtained from Eurostat (https://ec.europa.eu/eurostat/databrowser/view/proj_19np/default/table?lang=en).
The national reported and projected totals for 2019 and 2030 and the fraction of the population aged 30 years and above are given in Table 8.1.
Table 8.1. Inhabitants in the five Nordic countries in 2019 and 2030 (mio.) and the share of individuals aged 30+. Lowest panel displays the change in total population density from 2019 to 2030.
DK
FI
IS
NO
SE
Year
2019
2019
2019
2019
2019
Total
5.8
5.5
0.4
5.3
10.2
Above 30
3.7
3.7
0.2
3.4
6.5
Above 30 in %
64%
66%
59%
63%
64%
Year
2030
2030
2030
2030
2030
Total
6.0
5.5
0.4
5.8
11.1
Above 30
4.0
3.8
0.3
3.8
7.2
Above 30 in %
67%
70%
64%
66%
65%
Year
2019 to 2030
2019 to 2030
2019 to 2030
2019 to 2030
2019 to 2030
Difference in %
3%
0%
17%
8%
8%
Like in many other European countries, the inhabitants in the Nordic countries have increased their expected lifetime and the fraction of people older than 30 years are increasing slightly in all the Nordic countries towards 2030. The total population is also projected to increase between less than 1% (Finland) to about 17% (Iceland).
The spatial distribution of the gridded population data from 2018 is shown in Figure 8.1.
fig 8.1.png
Figure 8.1. Population density in the Nordic countries from Eurostat on 1 km x 1 km in 2018 (inhabitants/km2).

Standard costs for mortality and morbidity

The EVA model system applies a set of standard costs for acute and chronic mortality as well as for morbidity, derived for Denmark. To apply the EVA system for other countries, this set of standard costs can either be replaced by a set of locally developed standard costs that applies for the specific country, or be transformed to represent another country using the OECD benefit transfer methodology formula (OECD 2012: 138): 
VSLVN=VSLDK\left(\frac{YVN}{YDK}\right)^{\beta}
Here VSL is the value of a statistical life, and Y is the Gross Domestic Product (GDP) per capita (adjusted for purchasing power parity - PPP) and ß is the income elasticity based on the OECD central estimate.
The official VSL values for Denmark, Norway and Sweden were used to derive by benefit transfer VSL values for Finland and Iceland, which to our knowledge, that do not have official recommendations on VSL-values for socio-economic analysis. Subsequently we calculated a population weighted Nordic average for VSL.
The Nordic value of a life year (VOLY) were derived from the Nordic-VSL using the standard OECD methodology, whereby VSL is the net present value of the sum of discounted VOLY’s over the average remaining lifetime for a traffic fatality (see also DØRS, 2016). A declining discount rate of 3% for the first 35 years and 2% for the remaining time was used, derived with the Ramsey formula (cf. European Commission, 2014). The value of a chronic VOLY was calculated by assuming an average air pollution victim latency period of five years, cf. US-EPA methodology. A premature death is equivalent to a loss of 11.4 life years in Denmark, 10.4 years in Finland, 12.6 years in Iceland, 10.7 years in Norway and 9.5 years in Sweden.
Data for GDP has been obtained from Eurostat and results are provided as 2020-prices.
For morbidity, while the exposure-response functions reflect the background incidence in each of the Nordic countries, the unit costs (e.g. for hospitalizations) are derived from Danish circumstances.

Exposure-response relationships in EVA-system for current project

The assumptions related to exposure-response functions in this project are the same as in the version of the EVA-system used in the Danish national air quality monitoring program for 2020 (Ellermann et al., 2022). Exposure-response relationships in the applied version of the EVA-system are based on WHO (2013).
Assumptions about exposure-response relationships for the different pollutants are important especially for PM2.5 that is responsible for most of the health impacts. For PM2.5 we use a relative risk of 1.062 based on WHO (2013), that is, a 6.2% increase in mortality per 10 µg/m3 increase in annual mean PM2.5. Furthermore, no lower threshold of health effects for PM2.5 is assumed based on the precautionary principle. Available studies only include concentration levels down to 2.4 µg/m3 but the exposure-response relationships are stronger for lower levels compared with higher levels and health effects will most likely continue below 2.4 µg/m3 (WHO, 2021; Raaschou-Nielsen et al., 2020; Sommar et al., 2021). For NO2 a threshold of 20 µg/m3 (WHO, 2013) is assumed below which no effects occur. Health effects from ozone primarily originate from exposure to high concentrations, so a parameter (SOMO35) is used, where only ozone concentrations above 35 ppb (=70 μg/m3) are taken into account (WHO, 2013).
The assumptions about thresholds, relative risks (RR), age groups affected and the valuation of health endpoints are given in Table 8.2.
Table 8.2. The health endpoints and relative risks (RR) used in the EVA system for the present analysis. It is mainly based on a set of RR recommended by HRAPIE/WHO for use in health and cost assessments (Héroux et al., 2015). The RR for SO2 is taken from the ExternE project. The valuation (the standard costs) are based on work done in the NordicWelfAir project and represents the weighted average cost across the five Nordic countries (given in 2020 prices in Euros). 
Health endpoint
Pollutant
Range
Ages
RR per
10 μg/m3
Valuation
Mortality:
 
 
 
 
 
Acute mortality
O3
>35* ppb
all
1.0029
4526000 €/case
NO2 (1h max)
no thresh.
all
1.0027
4526000 €/case
PM2.5
no thresh.
all
1.0123
4526000 €/case
SO2
no thresh.
all
1.00072
4526000 €/case
Acute mortality infants
PPM2.5 (from PPM10)
no thresh.
Infants, post­neo­natal
1.0400
6789000 €/case
Chronic mortality
PM2.5
no thresh.
>30
1.062
141000 €/YOLL
NO2
>20 ug/m3
>30
1.0550
141000 €/YOLL
Hospital admissions (HA):
Cardiovascular HA/incl. stroke
PM2.5
no thresh.
all
1.0091
16494 €/case
Cardiovascular HA/excl. stroke
O3
>35* ppb
>65
1.0089
16368 €/case
Respiratory HA
PM2.5
no thresh.
all
1.0190
10247 €/case
Respiratory HA
O3
>35* ppb
>65
1.0044
10247 €/case
Respiratory HA
NO2
no thresh.
all
1.0180
10247 €/case
Bronchitis (KOL)/​children
PM2.5 from PM10
no thresh.
<16
1.0480
167  €/case
Bronchitis (KOL)/​adults
PM2.5 from PM10
no thresh.
>16
1.1170
40664  €/case
Asthma symptoms/​children
PM2.5 from PM10
no thresh.
<16
1.0280
1366  €/case
Days with restricted activity
(sick days) (RAD)
PM2.5
no thresh.
all
1.0470
160  €/day
Working days lost (WLD)
PM2.5
no thresh.
>30
1.0460
301 €/day
Days with minor restricted
activity (MRAD)
O3
>35* ppb
all
1.0154
81 €/day
Lung cancer morbidity
PM2.5
no thresh.
>30
1.14
74943 €/case
*Actually as SOMO35 calculated from the sum of the highest ozone concentrations, and indicates the sum of 8-hour daily maximum values over 35 ppb during the year.

Revisions and sensitivity analysis for Danish conditions

The exposure-response relationships in the EVA-system has been under revision during the course of the current project in light of the new WHO AQG from 2021 and the studies behind.
WHO’s new guidelines (WHO, 2021) encompass a thorough review of the international research on the association between exposure to a number of air pollutants and effects on human health. The review documents that the health impacts are larger than previously known and that the impacts on human health are observed at lower concentration levels than previously documented, which is of particular relevance for the Nordic countries with generally lower concentrations. For example, the relative risk for chronic mortality associated with PM2.5 has in the new guidelines increased from 1.062 to 1.08. Other things being equal, this will lead to higher estimates of health effects of air pollution.
The new guidelines from WHO have been implemented in the model calculations of the health impacts for Denmark in the most recent air quality assessment for 2021 (Ellermann et al., 2023). This has resulted in a change in the number of premature deaths originating from the different air pollutants. However, the overall number of premature deaths is approximately the same as previous years despite these changes. This is due to a parallel update of the average life expectancy and to the recommendation in the new WHO guidelines to use of a new lower threshold as well as changes in RRs for the health impact of NO2. The result is a lower number of premature deaths in general as well as from NO2 exposure, which balances out the higher number of premature deaths due to the change in RR for PM2.5.
A sensitivity analysis was also carried out in relation to the air quality assessment for 2021 for Denmark. The baseline assumes a relative risk for PM2.5 of 1.08 with no threshold value for this pollutant resulting in 3,900 premature deaths in Denmark. Scenarios with a relative risk for PM2.5 of 1.08 and a threshold of 2.4 µg/m3 gave 2,600 premature deaths, a relative risk for PM2.5 of 1.12 (as has been seen in Danish cohort studies, see Ellermann et al., 2023) and no threshold gave 5,800 premature deaths and a relative risk for PM2.5 of 1.12 and a threshold of 2.4 µg/m3 gave 3,800 premature deaths. This illustrates that prediction of the number of premature deaths is highly sensitive to the assumptions applied.

Emission sector contributions in selected Nordic countries

In the following sections we will provide information for each of the Nordic capital cities on mortality and morbidity effects of air pollution and related external costs in 2019 and 2030, and the contribution from different emission sectors as well as the contribution from the city, the country of the city and abroad sources. Estimates are based on calculations with DEHM, UBM and the EVA-system.

8.2 Health effects and sector contributions in København

Mortality and morbidity effects of air pollution in 2019 and 2030

A summary of mortality and morbidity effects of air pollution in 2019 and 2030 is shown in Table 8.3. Note that figures are rounded for case except for percentage figures.
Total premature deaths are predicted to be approx. 400 in 2019 and 300 in 2030 showing a decrease of approx. 20%. The decrease is a combined effect of an increase in population including more elderly persons and a decrease in air pollution levels. It is also seen that approx. 2/3 of the premature deaths are related to chronic premature deaths due to long-term exposure and approx. 1/3 to acute premature deaths due to short-term exposure with elevated air pollution levels.
The number of morbidity cases is also predicted to decrease from 2019 to 2030.
Aarhus University carried out a health impact assessment in 2019 for the Municipality of København that estimated 440 premature deaths, that is, in the same range as the above estimate as expected although also with some differences in the assumptions about the geographic extent of København, emissions, population data and life expectancy (Jensen et al. 2021).
Health effects
2019
2030
Difference
Acute mortality (PM2.5, SO2, NO2, O3)
140
110
-20%
Chronic mortality (PM2.5, NO2)
270
200
-23%
Total premature deaths (PM2.5, SO2, NO2, O3)
410
310
-22%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
490
410
-17%
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
130
120
-8%
Episodes with asthma among children (PM2.5)
30
25
-18%
Episodes with bronchitis among adults (PM2.5)
290
240
-17%
Episodes with bronchitis among children (PM2.5)
1300
1200
-11%
Working days lost (PM2.5)
18000
15000
-14%
Days with restricted activity (sick days) (PM2.5)
220000
190000
-17%
Days with minor restricted activity (O3)
35000
34000
-1%
Lung cancer morbidity (PM2.5)
50
45
-14%
Total inhabitants
594679
610810
3%
Inhabitants over age of 30 years
381011
406416
7%
Inhabitants over age of 30 years (%)
64%
67%
4%
Table 8.3.  Mortality and morbidity effects of air pollution in København in 2019 and 2030 (figures rounded).

Contribution of different emission sectors in 2030

The analysis of the contribution of the different emission sectors focuses on 2030 to illustrate the potential benefits of regulation of the different emission sectors in the future.
City to city
Table 8.4 shows the contribution to København of the emission sectors within København.
Approx. 50 premature deaths can be attributed to emission sources within the city equivalent to about 15% of the total number of premature deaths (310).
It is seen that the two single largest contributions to mortality and morbidity in 2030 are the emission sectors road transport (SNAP7) and residential wood combustion (SNAP2). Obviously, agriculture (SNAP10) does not contribute to premature deaths as there is very limited agriculture in København.
Negative values for days with minor restricted activity due to ozone is a result of chemistry in the atmosphere, where NOx emissions (NO+NO2) emitted in the city lead to lower ozone concentrations in the city as NO consumes ozone in formation of NO2.
Table 8.4. Contributions to mortality and morbidity in København from the emission sectors within København in 2030 (figures rounded).
 
City contribution to city 
City to city
Health effects of air pollution in 2030
SNAP2
SNAP7
SNAP8
SNAP10
SNAP134
SNAP569
All
Acute mortality (PM2.5, SO2, NO2, O3)
2
7
5
0
5
1
20
Chronic mortality (PM2.5, NO2)
7
7
2
0
7
1
24
Total premature deaths (PM2.5, SO2, NO2, O3)
10
15
7
0
12
3
47
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
7
24
14
0
16
2
64
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
3
1
-1
0
0
0
3
Episodes with asthma among children (PM2.5)
1
1
0
0
0
0
3
Episodes with bronchitis among adults (PM2.5)
8
7
1
0
2
2
20
Episodes with bronchitis among children (PM2.5)
28
23
2
0
6
5
63
Working days lost (PM2.5)
540
440
33
1
120
97
1200
Days with restricted activity (sick days) (PM2.5)
6500
5400
400
11
1400
1200
15000
Days with minor restricted activity (O3)
-220
-1300
-890
-1
-750
-110
-3200
Lung cancer morbidity (PM2.5)
2
1
0
0
0
0
4

Country to city

Table 8.5 shows the contribution to København from the emission sectors within Denmark disregarding emissions from København.
Residential wood combustion (SNAP2) is the emission sector with the largest contribution, followed by road transport. Off-road is also a relatively large contributor (SNAP8) as well as agriculture (SNAP10). The contribution from agriculture is related to ammonia emissions that are transformed to ammonium in the atmosphere and thereby becomes part of secondary particles contributing to PM2.5 as ammonium nitrate and ammonium sulphate.
The contribution from Danish emissions to premature deaths in København is approx. 70 which is about 23% of the total premature deaths in København.
Table 8.5. Contribution to mortality and morbidity in København from emission sectors in Denmark (excluding København) in 2030 (Figures rounded).
 
Contribution of Denmark to city
Denmark to city
Health effects of air pollution in 2030
SNAP2
SNAP7
SNAP8
SNAP10
SNAP134
SNAP569
All
Acute mortality (PM2.5, SO2, NO2, O3)
5
7
8
2
7
1
30
Chronic mortality (PM2.5, NO2)
13
8
4
6
5
2
38
Total premature deaths (PM2.5, SO2, NO2, O3)
19
16
13
8
12
3
71
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
15
23
22
7
19
3
89
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
5
2
0
3
1
1
11
Episodes with asthma among children (PM2.5)
2
1
0
1
1
0
5
Episodes with bronchitis among adults (PM2.5)
15
8
3
7
4
2
39
Episodes with bronchitis among children (PM2.5)
49
25
9
17
13
7
120
Working days lost (PM2.5)
970
490
190
420
270
140
250
Days with restricted activity (sick days) (PM2.5)
12000
5900
2300
5100
3200
1700
30000
Days with minor restricted activity (O3)
-320
-930
-1100
310
-420
89
-2400
Lung cancer morbidity (PM2.5)
3
2
1
1
1
1
8

Abroad to city

Table 8.6 shows a summary of the contribution from emissions abroad to the city together with city to city contribution and contribution from Denmark (with København excluded).
The contribution from abroad is only given as the total health effects and is not broken down on emission sectors.
The contribution from emissions abroad to premature deaths in København is approx. 140, which is about 63% of the total premature deaths in København.
Table 8.6. Summary of contributions from city to city, Denmark to city and contribution from abroad to health effects in København in 2030 (number of cases).
 
City to city
Denmark to city
Contribution from abroad
Total
Health effects of air pollution in 2030
All
All
All
All
Acute mortality (PM2.5, SO2, NO2, O3)
20
30
60
110
Chronic mortality (PM2.5, NO2)
24
38
140
200
Total premature deaths (PM2.5, SO2, NO2, O3)
50
70
200
310
Total premature deaths (percentage)
15%
23%
63%
100%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
64
89
250
410
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
3
11
110
120
Episodes with asthma among children (PM2.5)
3
5
17
25
Episodes with bronchitis among adults (PM2.5)
20
39
180
240
Episodes with bronchitis among children (PM2.5)
63
120
970
1200
Working days lost (PM2.5)
1200
2500
12000
15000
Days with restricted activity (sick days) (PM2.5)
15000
30000
140000
190000
Days with minor restricted activity (O3)
-3200
-2400
40000
34000
Lung cancer morbidity (PM2.5)
4
8
32
45
The contributions are also visualised as a histogram in Figure 8.2
Figure 8.2. Visualisation of emission sector contributions to the premature deaths in København in 2030. 

8.3 External costs and sector contributions in København

This section summarises the external costs of health effects in København in 2030 and the emission sector contributions to the costs.
The external costs will be similarly distributed as the health effects described in the previous section and hence a more concise description will be given in this section. The external costs are dominated by the costs associated with premature death.

External costs of health effects of air pollution in 2019 and 2030

The total costs of air pollution in København in 2019 is estimated to 1.1 billion EUR and 0.89 billion EUR in 2030. The decrease in costs is 21% from 2019 to 2030 similar to the predicted reduction in premature deaths of 22%.

External costs of mortality and morbidity of air pollution in 2030

The distribution of external costs on mortality and morbidity in 2030 is shown in Table 8.7.
Approx. 94% of the external costs in København in 2030 is associated with mortality and 6% with morbidity.
Health effects in 2030
Mio. EUR
%
Acute mortality (PM2.5, SO2, NO2, O3)
500
 
Chronic mortality (PM2.5, NO2)
330
Total premature deaths (PM2.5, SO2, NO2, O3)
830
94%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
4
 
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
2
Episodes with asthma among children (PM2.5)
0
Episodes with bronchitis among children and adults (PM2.5)
10
Working days lost (PM2.5)
5
Days with restricted activity (sick days) (PM2.5)
30
Days with minor restricted activity (O3)
3
Lung cancer morbidity (PM2.5)
3
Total morbidity
56
6%
Total premature death and morbidity
890
100%
Table 8.7. External costs of health effects in København in 2030 (mio. EUR).

Contribution of different emission sectors in 2030

The contribution to the external costs of different emission sectors as well as the contribution from the city, the country of the city and from sources abroad are for København shown in Table 8.8.
As expected the distribution of external costs closely follows the distribution of premature deaths shown in the previous section.
Table 8.8. Emission sector contributions to external costs of air pollution in København in 2030 (mio. EUR).
2030
City contribution to city
Contribution of Denmark to city
City to city
Denmark to city
Contri­bution from abroad
Total
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
All
All
All
Cost of health effects
25
48
25
0
35
7
48
48
46
20
41
9
140
210
530
890
Costs in %
3%
5%
3%
0%
4%
1%
5%
5%
5%
2%
5%
1%
16%
24%
60%
100%

8.4 Health effects and sector contributions in Stockholm

Mortality and morbidity effects of air pollution in 2019 and 2030

A summary of mortality and morbidity effects of air pollution in 2019 and 2030 is shown in Table 8.9.
The total number of premature deaths is predicted to approx. 600 in 2019 and approx. 500 in 2030 showing a decrease of approx. 19%. The decrease is a combined effect of an increase in population including more elderly persons and a decrease in air pollution levels. It is also seen that approx. 2/3 of premature deaths are related to chronic premature deaths due long-term exposure and approx. 1/3 to acute premature deaths due to short-term exposure to elevated air pollution levels.
The number of morbidity cases is predicted to decrease from 2019 to 2030.
Health effects
2019
2030
Difference
Acute mortality (PM2.5, SO2, NO2, O3)
200
160
-24%
Chronic mortality (PM2.5, NO2)
420
350
-17%
Total premature deaths (PM2.5, SO2, NO2, O3)
620
510
-19%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
590
470
-20%
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
180
180
-1%
Episodes with asthma among children (PM2.5)
42
37
-11%
Episodes with bronchitis among adults (PM2.5)
400
380
-5%
Episodes with bronchitis among children (PM2.5)
1700
1600
-5%
Working days lost (PM2.5)
81000
78000
-4%
Days with restricted activity (sick days) (PM2.5)
440000
410000
-6%
Days with minor restricted activity (O3)
52000
55000
4%
Lung cancer morbidity (PM2.5)
36
35
-4%
Total inhabitants
1064033
1154401
8%
Inhabitants over age of 30 years
677363
750685
11%
Inhabitants over age of 30 years (%)
64%
65%
2%
Table 8.9.  Mortality and morbidity effects of air pollution in Stockholm in 2019 and 2030.

Contribution of different emission sectors in 2030

The analysis of the contribution of the different emission sectors focuses on 2030 to illustrate the potential benefits of regulation of the different emission sectors in the future.
City to city
Table 8.10 shows the contribution to Stockholm of the emission sectors within Stockholm.
Approx. 200 premature deaths can be attributed to emission sources within the city, which is equivalent to about 35% of total premature deaths (500). The percentage attributed to emission sources within the city is higher for Stockholm compared with København (15%). Possible explanations could be that the geographic extent of Stockholm is larger and the population is also larger and background concentrations of (long-range transported) PM2.5 are lower.
It is seen that the single largest contribution to mortality and morbidity in 2030 is from the emission sector transport (SNAP7) and the combined sectors of energy, industrial combustion and industrial processes (SNAP134) are responsible for the second largest contribution whereas residential wood combustion (SNAP2) seems to be of less importance compared with København. Agriculture (SNAP10) does not contribute to premature deaths as there is very limited agriculture in Stockholm.
Negative values for days with minor restricted activity due to ozone is a result of chemistry in the atmosphere, where NOx emissions lead to lower ozone concentrations.
Table 8.10.  Contribution to mortality and morbidity in Stockholm from emission sectors in Stockholm in 2030 (figures rounded).
Health effects of air pollution in 2030
City contribution to city 
City to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
5
21
7
0
25
1
60
Chronic mortality (PM2.5, NO2)
14
50
8
0
36
7
110
Total premature deaths (PM2.5, SO2, NO2, O3)
19
71
15
0
61
8
180
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
13
53
21
0
47
2
140
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
4
14
1
0
8
3
29
Episodes with asthma among children (PM2.5)
2
5
1
0
3
1
11
Episodes with bronchitis among adults (PM2.5)
15
50
5
0
28
8
110
Episodes with bronchitis among children (PM2.5)
48
160
15
0
89
26
340
Working days lost (PM2.5)
3100
10000
950
1
5700
1700
22000
Days with restricted activity (sick days) (PM2.5)
16000
55000
5000
8
30000
8700
110000
Days with minor restricted activity (O3)
-500
-2100
-940
-5
-1300
-6
-4900
Lung cancer morbidity (PM2.5)
1
5
0
0
3
1
10

Country to city

Table 8.11 shows the contribution to Stockholm from the emission sectors within Sweden disregarding emissions from Stockholm.
The contribution from Swedish emissions to premature deaths in Stockholm is approx. 90 which is about 18% of total premature deaths in Stockholm.
The three largest contributions to health effects are from the emission sectors road transport (SNAP7), residential wood combustion (SNAP2) and the combined sectors of energy, industrial combustion and industrial processes (SNAP134). Off-road emissions also contribute (SNAP8) as well as agriculture (SNAP10). The contribution from agriculture is related to ammonia emissions that are transformed to ammonium nitrate and ammonium sulphate in the atmosphere and thereby becomes part of secondary particles of PM2.5.
Table 8.11.  Contribution to mortality and morbidity in Stockholm from emission sectors in Sweden in 2030 (figures rounded).
 
Health effects of air pollution in 2030
Contribution of Sweden to city 
Sweden to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
5
10
4
1
7
1
28
Chronic mortality (PM2.5, NO2)
14
25
4
5
10
4
63
Total premature deaths (PM2.5, SO2, NO2, O3)
19
35
8
6
17
5
90
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
11
25
10
4
14
2
66
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
5
8
1
2
4
2
23
Episodes with asthma among children (PM2.5)
2
3
0
1
1
1
7
Episodes with bronchitis among adults (PM2.5)
16
27
4
5
11
5
67
Episodes with bronchitis among children (PM2.5)
50
84
12
14
32
15
200
Working days lost (PM2.5)
3200
5500
820
1100
2200
1000
14000
Days with restricted activity (sick days) (PM2.5)
17000
29000
4300
5700
11000
5400
73000
Days with minor restricted activity (O3)
-1
-300
-15
440
350
140
610
Lung cancer morbidity (PM2.5)
1
2
0
0
1
0
6

Abroad to city

Table 8.12 shows a summary of the contribution from emissions abroad to the city together with city-to-city contribution and contribution from Sweden (excluding the city).
The contribution from abroad is only given as the total health effects and is not broken down on emission sectors.
The contribution from emissions abroad to premature deaths in Stockholm is approx. 240, which is about 47% of the total premature deaths in Stockholm. The percentage is lower than for København (63%) due to lower background concentration of PM2.5 in Stockholm compared with København, but also because the contribution from Stockholm itself plays a larger role as explained above.
 
City to city
Country to city
Contri­bution from abroad
Total
Health effects of air pollution in 2030
All
All
All
All
Acute mortality (PM2.5, SO2, NO2, O3)
60
28
68
160
Chronic mortality (PM2.5, NO2)
120
63
170
350
Total premature deaths (PM2.5, SO2, NO2, O3)
180
90
240
500
Total premature deaths (percentage)
35%
18%
47%
100%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
140
66
270
470
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
29
23
130
180
Episodes with asthma among children (PM2.5)
11
7
19
37
Episodes with bronchitis among adults (PM2.5)
110
67
210
380
Episodes with bronchitis among children (PM2.5)
340
210
1100
1600
Working days lost (PM2.5)
22000
14000
43000
78000
Days with restricted activity (sick days) (PM2.5)
115000
73000
230000
410000
Days with minor restricted activity (O3)
-4900
610
59000
55000
Lung cancer morbidity (PM2.5)
10
6
20
35
Table 8.12. Summary of contributions from city to city, country to city and contribution from abroad to health effects in Stockholm in 2030 (number of cases). (Figures rounded).
The contributions are also visualised as a histogram in Figure 8.3.
Figure 8.3. Visualisation of emission sector contributions to premature deaths in Stockholm in 2030.

8.5 External costs and sector contributions in Stockholm

This section summarises the external costs of health effects in Stockholm in 2030 and emission sector contributions.
The external costs will be similarly distributed as the health effects and hence a more concise description for external costs is given in the following. The external costs are dominated by the costs associated with premature mortality. The number of premature deaths is dominated by chronic deaths whereas costs are dominated by acute deaths due to the higher costs for acute deaths compared with chronic deaths.

External costs of health effects of air pollution in 2019 and 2030

The total costs of air pollution in Stockholm in 2019 is estimated to 1.6 billion EUR and to 1.3 billion EUR in 2030. The decrease in costs is 20% from 2019 to 2030, similar to the predicted reduction in premature deaths of 19%.

External costs of mortality and morbidity of air pollution in 2030

The distribution of external costs on mortality and morbidity in 2030 is shown in Table 8.13.
Approx. 91% of the external costs in Stockholm in 2030 is associated with mortality and 9% with morbidity, similar to results from København (94%/6%).
Health effects in 2030
Mio. EUR
%
Acute mortality (PM2.5, SO2, NO2, O3)
710
Chronic mortality (PM2.5, NO2)
460
Total premature deaths (PM2.5, SO2, NO2, O3)
1200
91%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
5
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
3
Episodes with asthma among children (PM2.5)
0
Episodes with bronchitis among children and adults (PM2.5)
16
Working days lost (PM2.5)
24
Days with restricted activity (sick days) (PM2.5)
66
Days with minor restricted activity (O3)
4
Lung cancer morbidity (PM2.5)
3
Total morbidity
120
9%
Total premature death and morbidity
1300
100%
Table 8.13. External costs of health effects in Stockholm in 2030 (million EUR) (rounded figures).

Contribution of different emission sectors in 2030

The contribution to external costs of different emission sectors as well as the contribution from the city, the country of the city and from sources abroad are for Stockholm shown in Table 8.14.
As expected the distribution of external costs closely follows the distribution of premature deaths shown in the previous section.
Table 8.14. Sector contributions to external costs of air pollution in Stockholm in 2030 (mio. EUR). (Rounded figures).
2030
City contribution to city
Contribution of Sweden to city
City
Sweden
Abroad
Total
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
All
All
All
Cost of health effects
47
180
46
0
170
18
45
88
23
15
47
11
460
230
600
1290
Costs in %
4%
14%
4%
0%
13%
1%
3%
7%
2%
1%
4%
1%
36%
18%
47%
100%

8.6 Health effects and sector contributions in Helsinki

Mortality and morbidity effects of air pollution in 2019 and 2030

A summary of mortality and morbidity effects of air pollution in 2019 and 2030 is shown in Table 8.15.
Total premature deaths are predicted to approx. 390 in 2019 and 330 in 2030 showing a decrease of approx. 15%. The decrease is a combined effect of an increase in population including more elderly persons and a decrease in air pollution levels. It is also seen that approx. 60% of premature deaths are related to chronic premature deaths due long-term exposure and approx. 40% to acute premature deaths due to short-term exposure with elevated air pollution levels.
The number of morbidity cases is also predicted to decrease from 2019 to 2030.
Health effects
2019
2030
Difference
Acute mortality (PM2.5, SO2, NO2, O3)
170
140
-18%
Chronic mortality (PM2.5, NO2)
220
190
-13%
Total premature deaths (PM2.5, SO2, NO2, O3)
390
330
-15%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
460
370
-19%
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
120
110
-7%
Episodes with asthma among children (PM2.5)
40
29
-29%
Episodes with bronchitis among adults (PM2.5)
230
200
-11%
Episodes with bronchitis among children (PM2.5)
930
750
-19%
Working days lost (PM2.5)
17000
16000
-9%
Days with restricted activity (sick days) (PM2.5)
180000
160000
-13%
Days with minor restricted activity (O3)
16000
16000
-1%
Lung cancer morbidity (PM2.5)
26
23
-9%
Total inhabitants
687693
687865
0%
Inhabitants over age of 30 years
456697
478652
5%
Inhabitants over age of 30 years (%)
66%
70%
5%
Table 8.15.  Mortality and morbidity effects of air pollution in Helsinki in 2019 and 2030. (Rounded figures).

Contribution of different emission sectors in 2030

The analysis of the contribution of the different emission sectors focuses on 2030 to illustrate the potential benefits of regulation of the different emission sectors in the future.
City to city
Table 8.16 shows the contribution to Helsinki of the emission sectors within Helsinki.
Approx. 80 premature deaths can be attributed to emission sources within the city, equivalent to about 25% of total premature deaths (330). The percentage attributed to emission sources within the city is higher than for København (15%), but lower than for Stockholm (35%). Possible explanations could be that the size of the population in Helsinki is similar to København, but background concentrations of PM2.5 are lower.
The largest contribution comes from the combined sectors of energy, industrial combustion and industrial processes (SNAP134), but the largest single contribution is from the emission sector road transport (SNAP7). Residential wood combustion (SNAP2) has the fourth largest contribution. Agriculture (SNAP10) does not contribute to premature deaths as there is very limited agriculture in Helsinki.
Negative values for days with minor restricted activity due to ozone is a result of chemistry in the atmosphere, where NOx emissions lead to lower ozone concentrations.
Table 8.16.  Contribution to mortality and morbidity in Helsinki from emission sectors in Helsinki in 2030. (Figures rounded).
 
Health effects of air pollution in 2030
City contribution to city
City to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
1
7
5
0
35
1
48
Chronic mortality (PM2.5, NO2)
5
14
4
0
8
3
35
Total premature deaths (PM2.5, SO2, NO2, O3)
6
21
9
0
43
3
83
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
4
22
16
0
54
1
96
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
2
4
0
0
-2
1
5
Episodes with asthma among children (PM2.5)
1
2
1
0
1
0
4
Episodes with bronchitis among adults (PM2.5)
5
15
4
0
5
3
32
Episodes with bronchitis among children (PM2.5)
14
38
9
1
13
8
83
Working days lost (PM2.5)
420
1100
270
17
390
230
2400
Days with restricted activity (sick days) (PM2.5)
4300
12000
2800
170
4000
2400
25000
Days with minor restricted activity (O3)
-82
-780
-810
-2
-2100
-4
-3800
Lung cancer morbidity (PM2.5)
1
2
0
0
0
0
3

Contribution from Finland to city

Table 8.17 shows the contribution to Helsinki from the emission sectors within Finland disregarding emissions from Helsinki.
The contribution from emissions in Finland to premature deaths in Helsinki is approx. 70 which is about 21% of total premature deaths in Helsinki.
The three emission sectors with the largest contribution to health effects are the combined sectors of energy, industrial combustion and industrial processes (SNAP134), road transport (SNAP7) and residential wood combustion (SNAP2). Off-road emissions are also contributing (SNAP8) as well as agriculture (SNAP10). The contribution from agriculture is related to ammonia emissions that are transformed to ammonium nitrate and ammonium sulphate in the atmosphere and thereby become part of secondary particles of PM2.5.
Table 8.17.  Contribution to mortality and morbidity in Helsinki from emission sectors in Finland in 2030.
 
Health effects of air pollution in 2030
Contribution of Finland to city
Finland to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
3
6
3
1
14
0
27
Chronic mortality (PM2.5, NO2)
12
13
5
2
8
2
43
Total premature deaths (PM2.5, SO2, NO2, O3)
16
19
8
3
22
2
70
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
9
19
10
3
35
1
77
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
5
5
2
1
1
1
15
Episodes with asthma among children (PM2.5)
2
2
1
0
1
0
6
Episodes with bronchitis among adults (PM2.5)
13
14
5
2
7
2
42
Episodes with bronchitis among children (PM2.5)
34
35
12
5
16
4
110
Working days lost (PM2.5)
1000
1100
390
190
520
130
3300
Days with restricted activity (sick days) (PM2.5)
10000
11000
4000
1900
5300
1300
34000
Days with minor restricted activity (O3)
-120
-390
-210
140
-650
33
-1200
Lung cancer morbidity (PM2.5)
1
1
0
0
1
0
4

Abroad to city

Table 8.18 shows a summary of the contribution from abroad to the city together with city to city contribution and contribution from Finland.
The contribution from abroad is only given as the total health effects and is not broken down on emission sectors.
The contribution from emissions abroad to premature deaths in Helsinki is approx. 180 which is about 53% of total premature deaths in Helsinki. The percentage is comparable to Stockholm (47%) for the same reasons as given for Stockholm when compared with København.
 
City to city
Country to city
Contribution from abroad
Total
Health effects of air pollution in 2030
All
All
All
All
Acute mortality (PM2.5, SO2, NO2, O3)
48
27
66
140
Chronic mortality (PM2.5, NO2)
35
43
110
190
Total premature deaths (PM2.5, SO2, NO2, O3)
83
70
180
330
Total premature deaths (percentage)
25%
21%
53%
100%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
96
77
200
370
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
5
15
87
110
Episodes with asthma among children (PM2.5)
4
6
18
29
Episodes with bronchitis among adults (PM2.5)
32
42
130
200
Episodes with bronchitis among children (PM2.5)
83
110
560
750
Working days lost (PM2.5)
2400
3300
9800
16000
Days with restricted activity (sick days) (PM2.5)
25000
34000
100000
160000
Days with minor restricted activity (O3)
-3800
-1200
21000
16000
Lung cancer morbidity (PM2.5)
3
4
16
23
Table 8.18. Summary of contributions from city to city, country to city and contribution from abroad to health effects in Helsinki in 2030 (number of cases).
The contributions are also visualised as a histogram in Figure 8.4.
Figure 8.4. Visualisation of emission sector contributions to premature deaths in Helsinki in 2030. 

8.7 External costs and sector contributions in Helsinki

This section summarises the external costs of health effects in Helsinki in 2030 and the emission sector contributions.
The external costs are dominated by the costs associated with premature mortality. The number of premature deaths are dominated by the chronic deaths whereas costs are dominated by acute deaths due to the higher costs for acute deaths compared with chronic deaths.

External costs of health effects of air pollution in 2019 and 2030

The total costs of air pollution in Helsinki in 2019 is estimated to 1.2 billion EUR and 0.9 billion EUR in 2030. The decrease in costs is 16% from 2019 to 2030 similar to the predicted reduction in premature deaths of 15%.

External costs of mortality and morbidity of air pollution in 2030

The distribution of external costs on mortality and morbidity in 2030 is shown in Table 8.19.
Approx. 95% of the external costs in Helsinki in 2030 is associated with mortality and 5% with morbidity similar to results from København (94%/6%) and Stockholm (91%/9%).
Health effects in 2030
Mio. EUR
%
Acute mortality (PM2.5, SO2, NO2, O3)
640
Chronic mortality (PM2.5, NO2)
280
Total premature deaths (PM2.5, SO2, NO2, O3)
920
95%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
4
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
2
Episodes with asthma among children (PM2.5)
0
Episodes with bronchitis among children and adults (PM2.5)
8
Working days lost (PM2.5)
5
Days with restricted activity (sick days) (PM2.5)
25
Days with minor restricted activity (O3)
1
Lung cancer morbidity (PM2.5)
2
Total morbidity
50
5%
Total premature death and morbidity
960
100%
Table 8.19. External costs of health effects in Helsinki in 2030 (mio. EUR). (Figures rounded).

Contribution of different emission sectors in 2030

The contribution to external costs of different emission sectors as well as the contribution from the city, the country of the city and sources from abroad are for Helsinki shown in Table 8.20.
As expected the distribution of external costs closely follows the distribution of premature deaths shown in the previous section.
Table 8.20. Sector contributions to external costs of air pollution in Helsinki in 2030 (million EUR). (Figures rounded).
2030
City contribution to city
Contribution of Finland to city
City
Finland
Abroad
Total
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
All
All
All
Cost of health effects
15
55
29
1
170
8
37
48
22
8
77
4
280
200
490
960
Costs in %
2%
6%
3%
0%
18%
1%
4%
5%
2%
1%
8%
0%
29%
20%
51%
100%

8.9 Health effects and sector contributions in Reykjavík

Mortality and morbidity effects of air pollution in 2019 and 2030

A summary of mortality and morbidity effects of air pollution in 2019 and 2030 is shown in Table 8.21.
Total premature deaths are predicted to approx. 39 in 2019 and also 39 in 2030. The reason why the number of premature deaths is not changing is a combined effect of a large increase in population including more elderly persons and a decrease in air pollution levels.
Health effects
2019
2030
Difference
Acute mortality (PM2.5, SO2, NO2, O3)
22
21
-5%
Chronic mortality (PM2.5, NO2)
16
18
9%
Total premature deaths (PM2.5, SO2, NO2, O3)
39
39
1%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
57
58
2%
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
13
14
9%
Episodes with asthma among children (PM2.5)
6
6
-8%
Episodes with bronchitis among adults (PM2.5)
36
37
4%
Episodes with bronchitis among children (PM2.5)
200
300
9%
Working days lost (PM2.5)
3900
4300
9%
Days with restricted activity (sick days) (PM2.5)
31400
32000
2%
Days with minor restricted activity (O3)
11900
11500
-3%
Lung cancer morbidity (PM2.5)
3
4
9%
Total inhabitants
226661
264756
17%
Inhabitants over age of 30 years
134433
168473
25%
Inhabitants over age of 30 years (%)
59%
64%
7%
Table 8.21.  Mortality and morbidity effects of air pollution in Reykjavík in 2019 and 2030. (Figures rounded).

Contribution of different emission sectors in 2030

The analysis of the contribution of the different emission sectors focuses on 2030 to illustrate the potential benefits of regulation of the different emission sectors in the future.

City to city

Table 8.22 shows the contribution to Reykjavík of the emission sectors within Reykjavík.
Approx. 17 premature deaths can be attributed to emission sources within the city equivalent to about 43% of total premature deaths (39). The percentage attributed to emission sources within the city is higher than for København (15%), Helsinki (25%) and Stockholm (35%). The reason is mainly related to the location of Iceland in the North Atlantic Ocean with relative low contributions from emission sources abroad.
The contribution from different emission sources in Reykjavík shows a very different pattern than for the other Nordic capital cities. The largest contribution comes from the off-road sector (SNAP8) related to the fishing fleet. However, in the emission inventory these emissions are allocated to harbour areas and therefore the concentration contributions from this sector is overestimated as emissions correctly should be allocated to sea areas. Residential wood combustion (SNAP2) is insignificant.
Negative values for days with minor restricted activity due to ozone is a result of chemistry in the atmosphere, where NOx emissions lead to lower ozone concentrations.
Table 8.22. Contribution to mortality and morbidity in Reykjavík from emission sectors in Reykjavík in 2030.
 
Health effects of air pollution in 2030
City contribution to city
City to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
0
1
11
2
1
0
15
Chronic mortality (PM2.5, NO2)
0
1
1
0
0
1
4
Total premature deaths (PM2.5, SO2, NO2, O3)
0
2
12
2
1
0
17
Hospital admissions due to respiratory symptoms (PM2.5, NO2 ,O3)
0
1
22
4
1
0
28
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
0
0
-1
0
0
0
0
Episodes with asthma among children (PM2.5)
0
0
0
0
0
0
1
Episodes with bronchitis among adults (PM2.5)
0
2
2
0
1
1
7
Episodes with bronchitis among children (PM2.5)
0
8
8
0
2
3
21
Working days lost (PM2.5)
2
256
258
8
74
95
694
Days with restricted activity (sick days) (PM2.5)
14
1912
1926
62
552
708
5175
Days with minor restricted activity (O3)
-9
-103
-2522
-425
-46
-3
-3108
Lung cancer morbidity (PM2.5)
0
0
0
0
0
0
1

Contribution from Iceland to city

Table 8.23 shows the contribution to Reykjavík from the emission sectors within Iceland disregarding emissions from Reykjavík.
The contribution from emissions in Iceland to premature deaths in Reykjavík is approx. 11 which is about 27% of total premature deaths in Reykjavík.
The two largest contributions to health effects come from emissions from the off-road sector (SNAP8) and the combined sector of energy, industrial combustion and industrial processes (SNAP134).
Table 8.23. Contribution to mortality and morbidity in Reykjavík from emission sectors in Iceland in 2030. (Rounded figures).
 
Health effects of air pollution in 2030
Contribution of Iceland to city
Iceland to city
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
Acute mortality (PM2.5, SO2, NO2, O3)
0
0
5
1
2
0
8
Chronic mortality (PM2.5, NO2)
0
0
1
1
1
0
4
Total premature deaths (PM2.5, SO2, NO2, O3)
0
0
6
1
3
0
11
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
0
0
13
1
2
0
16
Hospital admissions due to cardio-vascular diseases (PM2.5 ,O3)
0
0
0
0
1
0
1
Episodes with asthma among children (PM2.5)
0
0
0
0
0
0
1
Episodes with bronchitis among adults (PM2.5)
0
1
3
2
3
1
9
Episodes with bronchitis among children (PM2.5)
0
2
9
2
8
1
23
Working days lost (PM2.5)
1
85
308
213
282
44
933
Days with restricted activity (sick days) (PM2.5)
8
632
2299
1589
2102
326
6957
Days with minor restricted activity (O3)
21
12
-1095
14
-15
-4
-1067
Lung cancer morbidity (PM2.5)
0
0
0
0
0
0
1

Contribution to city from emissions from abroad

Table 8.24 shows a summary of the contribution from abroad to the city together with city to city contribution and contribution from Iceland.
The contribution from abroad is only given as the total health effects and is not broken down on emission sectors.
The contribution from emissions from abroad to premature deaths in Reykjavík is approx. 11 which is only approx. 30% of the total premature deaths in Reykjavík. The percentage is the lowest compared with the other Nordic capital cities. The reason is the relatively low PM2.5 concentrations causing less chronic mortality compared with other capital cities.
Health effects of air pollution in 2030
City to city
Country to city
Contri­bution from abroad
Total
All
All
All
All
Acute mortality (PM2.5, SO2, NO2, O3)
15
8
-2
21
Chronic mortality (PM2.5, NO2)
4
4
9
18
Total premature deaths (PM2.5, SO2, NO2, O3)
17
11
11
39
Total premature deaths (percentage)
43%
27%
30%
100%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
28
16
14
58
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
0
1
13
14
Episodes with asthma among children (PM2.5)
1
1
4
6
Episodes with bronchitis among adults (PM2.5)
7
9
21
37
Episodes with bronchitis among children (PM2.5)
21
23
258
302
Working days lost (PM2.5)
694
933
2656
4282
Days with restricted activity (sick days) (PM2.5)
5175
6957
19802
31934
Days with minor restricted activity (O3)
-3108
-1067
15651
11475
Lung cancer morbidity (PM2.5)
1
1
1
4
Table 8.24. Summary of contributions from city to city, country to city and contribution from abroad to health effects in Reykjavík in 2030 (number of cases).
The contributions are also visualised as a histogram in Figure 8.5.
Figure 8.5. Visualisation of emission sector contributions to premature deaths in Reykjavík in 2030. 

8.10 External costs and sector contributions in Reykjavík

This section summarises the external costs of health effects in Reykjavík in 2030 and sector contributions.
The external costs are dominated by the costs associated with premature mortality. In case of Reykjavík, the number of premature deaths are dominated by acute deaths, which is different from the other Nordic capital cities where chronic deaths dominate.

External costs of health effects of air pollution in 2019 and 2030

The total costs of air pollution in Reykjavík in 2019 is estimated to 0.14 billion EUR and also 0.14 billion EUR in 2030. The costs are the same in 2019 and 2030 similar to the predicted number of premature deaths.

External costs of mortality and morbidity of air pollution in 2030

The distribution of external costs on mortality and morbidity in 2030 is shown in Table 8.25.
Approx. 93% of the external costs in Reykjavík in 2030 is associated with mortality and 7% with morbidity similar to results from København (94%/6%), Stockholm (91%/9%) and Helsinki (95%/5%).
Health effects in 2030
Mio. EUR
%
Acute mortality (PM2.5, SO2, NO2, O3)
96
Chronic mortality (PM2.5, NO2)
31
Total premature deaths (PM2.5, SO2, NO2, O3)
127
93%
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
1
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
0
Episodes with asthma among children (PM2.5)
0
Episodes with bronchitis among children and adults (PM2.5)
2
Working days lost (PM2.5)
1
Days with restricted activity (sick days) (PM2.5)
5
Days with minor restricted activity (O3)
1
Lung cancer morbidity (PM2.5)
0
Total morbidity
10
7%
Total premature death and morbidity
138
100%
Table 8.25. External costs of health effects in Reykjavík in 2030 (million EUR).

Contribution of different emission sectors in 2030

The contribution to external costs of different emission sectors as well as the contribution from the city, the country of the city and sources from abroad are for Reykjavík shown in Table 8.26.
As expected the distribution of external costs closely follows the distribution of premature deaths shown in the previous section.
Table 8.26. Sector contributions to external costs of air pollution in Reykjavík in 2030 (mio. EUR).
2030
City contribution to city
Contribution of Iceland to city
City
Iceland
Abro-ad
Total
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
SNAP​2
SNAP​7
SNAP​8
SNAP​10
SNAP​134
SNAP​569
All
All
All
All
Cost of health effects
0
5
51
7
6
1
0
1
24
4
11
1
70
41
26
137
Costs in %
0%
4%
37%
5%
4%
1%
0%
1%
18%
3%
8%
1%
51%
30%
19%
100%

8.11 Health effects in Oslo

Data for 2030 is not available for Oslo due to data problems described in chapter 5, and hence health effects and related costs as well as sector contributions are not available.

Mortality and morbidity effects of air pollution in 2019

A summary of mortality and morbidity effects of air pollution for Oslo in 2019 is shown in Table 8.27.
The total number of premature deaths is calculated to approx. 450 in 2019.
Health effects
2019
Acute mortality (PM2.5, SO2, NO2, O3)
130
Chronic mortality (PM2.5, NO2)
320
Total premature deaths (PM2.5, SO2, NO2, O3)
450
Hospital admissions due to respiratory symptoms (PM2.5, NO2, O3)
490
Hospital admissions due to cardio-vascular diseases (PM2.5, O3)
150
Episodes with asthma among children (PM2.5)
24
Episodes with bronchitis among adults (PM2.5)
390
Episodes with bronchitis among children (PM2.5)
1600
Working days lost (PM2.5)
25000
Days with restricted activity (sick days) (PM2.5)
300000
Days with minor restricted activity (O3)
21000
Lung cancer morbidity (PM2.5)
52
Total inhabitants
697526
Inhabitants over age of 30 years
439860
Inhabitants over age of 30 years (%)
63%
Table 8.27.  Mortality and morbidity effects of air pollution in Oslo in 2019.
It is also for Oslo seen that approx. 2/3 of the premature deaths are related to chronic premature deaths due long-term exposure and approx. 1/3 to acute premature deaths due to short-term exposure with elevated air pollution levels.

8.12 External costs in Oslo

This section summarises the external costs of health effects in Oslo.
The external costs are dominated by the costs associated with premature mortality. The number of premature deaths is dominated by chronic deaths whereas costs are dominated by acute deaths due to higher costs for acute deaths compared with chronic deaths.
The total costs of air pollution in Oslo in 2019 is estimated to 1.2 billion EUR.

8.13 Summary of health effects and costs for capital cities

Premature mortality

A summary of the number of premature deaths in the Nordic capital cities due to air pollution is given in Table 8.28.
Key factors in determination of the number of premature deaths are air quality levels of PM2.5, NO2 and O3 and the number of inhabitants. This is also evident from the results in Table 8.28. Although populations are expected to grow from 2019 to 2030, premature deaths are predicted to decrease as air quality improves.
 
Area (km2)
Inhabitants in 2019
Inhabitants in 2030
2019
2030
Differ­ence
København
95
594,679
610,810
410
310
-22%
Stockholm
207
1,064,033
1,154,401
620
510
-19%
Helsinki
195
687,693
687,865
390
330
-15%
Reykavik
173
226,661
264,756
39
39
1%
Oslo
262
664,000
697,526
450
n.a.
n.a.
Table 8.28. Number of premature deaths in the capital cities in 2019 and 2030.
The distribution of premature death caused by emissions from the city, from the country and from abroad for the Nordic capital cities is shown in Table 8.29.
The contribution from the city ranges from 15% to 43%, from the country from 18% to 27% and from abroad from 30% to 60%. Reykjavík has the highest contribution from the city and the lowest from abroad. The opposite picture is seen for København with the lowest contribution from the city and the highest contribution from abroad.
 
From city
From country
From abroad
Total
København
15%
23%
63%
100%
Stockholm
35%
18%
47%
100%
Helsinki
25%
21%
53%
100%
Reykavík
43%
27%
30%
100%
Oslo
n.a.
n.a.
n.a.
n.a.
Table 8.29. Percentage of premature deaths in the Nordic capital cities in 2030 distributed on contributions from city to city, from country and from abroad.

External costs

The external costs related to air pollution for the capital cities are given in Table 8.30.
 
Area (km2)
Inhabitants in 2019
Inhabitants in 2030
2019
2030
Differ­ence
København
95
594,679
610,810
1.1
0.9
-21%
Stockholm
207
1,064,033
1,154,401
1.6
1.3
-20%
Helsinki
195
687,693
687,865
1.2
0.9
-16%
Reykavík
173
226,661
264,756
0.14
0.14
-2%
Oslo
262
664,000
697,526
1.2
n.a.
n.a.
Table 8.30. External costs related to health effects of air pollution in capital cities in 2019 and 2030. Billion EUR.